NGVT

+ Watchlist + Portfolio

Ingevity Corp.

Cyclical demand Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $71.09
52-Week Range: $45.85 – $79.29
Market Cap: $2.49B
P/E (TTM): 103.44
EPS (TTM): 0.70
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 53.24
PEG Ratio: 2.41
Return on Equity: 30.07%
Return on Assets: 10.41%
Gross Margin: 41.13%
Operating Margin: 29.90%
Profit Margin: 4.65%
Current Ratio: 1.61
Debt/Equity: 26.36
Total Debt: $1.24B
Free Cash Flow: $88.94M
Revenue Growth: -5.20%
Earnings Growth: —
Enterprise Value: $3.63B

NGVT Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$1.67B	$1.22B	$1.20B	$1.17B
Cost of Revenue	$1.10B	$770.50M	$735.30M	$706.10M
Gross Profit	$570.10M	$445.00M	$464.80M	$461.50M
Research & Development	$30.30M	$25.40M	$24.50M	$28.40M
Selling, General & Admin	$198.80M	$161.80M	$157.80M	$171.20M
Operating Expenses	$229.10M	$187.20M	$182.30M	$199.60M
Operating Income	$341.00M	$257.80M	$282.50M	$261.90M
EBITDA	$440.20M	$345.50M	$64.40M	$41.40M
Pretax Income	$269.60M	$130.00M	-$140.50M	-$142.10M
Income Tax	$58.00M	$24.20M	-$19.10M	$8.20M
Net Income	$211.60M	-$5.40M	-$430.30M	-$167.10M
Diluted EPS	5.50	-0.15	-11.85	-4.61
Diluted Shares	38.50M	36.50M	36.30M	36.20M

NGVT Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$76.70M	$95.90M	$68.00M	$78.10M
Receivables	$249.30M	$211.00M	$162.70M	$157.80M
Inventory	$335.00M	$308.80M	$195.90M	$186.00M
Current Assets	$683.30M	$658.60M	$493.20M	$454.20M
Total Assets	$2.74B	$2.62B	$2.02B	$1.65B
Current Liabilities	$303.50M	$362.90M	$264.10M	$341.30M
Long-Term Debt	$1.47B	$1.38B	$1.34B	$1.16B
Total Debt	$1.53B	$1.53B	$1.45B	$1.24B
Total Liabilities	$2.04B	$1.99B	$1.83B	$1.62B
Retained Earnings	$1.01B	$1.00B	$572.00M	$404.90M
Shareholders' Equity	$698.30M	$631.40M	$195.20M	$29.70M
Working Capital	$379.80M	$295.70M	$229.10M	$112.90M
Net Debt	$1.40B	$1.37B	$1.33B	$1.13B

NGVT Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$313.40M	$205.10M	$128.60M	$331.20M
Capital Expenditure	-$142.50M	-$109.80M	-$77.60M	-$57.70M
Free Cash Flow	$170.90M	$95.30M	$51.00M	$273.50M
Depreciation & Amortisation	$108.80M	$122.80M	$108.30M	$106.40M
Stock-Based Compensation	$16.10M	$10.60M	$11.90M	$18.30M
Investing Cash Flow	-$551.90M	-$77.30M	-$79.50M	-$57.50M
Financing Cash Flow	$48.10M	-$99.90M	-$70.20M	-$252.20M
Share Repurchases	-$145.20M	-$92.10M	$0.00	-$56.30M
Net Change in Cash	-$190.40M	$27.90M	-$21.10M	$21.50M

NGVT Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$331.50M	$333.10M	$255.10M	$258.00M	$314.10M
Cost of Revenue	$203.70M	$199.20M	$167.30M	$141.60M	$175.10M
Gross Profit	$127.80M	$133.90M	$87.80M	$116.40M	$139.00M
Research & Development	$7.00M	$7.00M	$7.40M	$6.70M	$6.10M
Selling, General & Admin	$43.60M	$44.10M	$41.60M	$40.70M	$39.00M
Operating Expenses	$50.60M	$51.10M	$49.00M	$47.40M	$45.10M
Operating Income	$77.20M	$82.80M	$38.80M	$69.00M	$93.90M
EBITDA	-$91.00M	$109.80M	-$60.80M	$69.90M	$88.00M
Pretax Income	-$136.60M	$62.20M	-$105.40M	$30.20M	$50.70M
Income Tax	$4.80M	$21.40M	-$26.60M	$6.80M	$10.90M
Net Income	-$146.50M	$43.50M	-$84.60M	$59.80M	$35.30M
Diluted EPS	-4.02	1.18	-2.37	1.66	1.00
Diluted Shares	36.50M	37.00M	35.70M	36.00M	35.30M

NGVT Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$76.90M	$83.40M	$78.10M	$95.40M	$97.40M
Receivables	$193.40M	$168.10M	$157.80M	$151.20M	$155.80M
Inventory	$220.30M	$193.70M	$186.00M	$203.60M	$154.00M
Current Assets	$536.00M	$522.20M	$454.20M	$581.80M	$543.80M
Total Assets	$1.88B	$1.83B	$1.65B	$1.65B	$1.54B
Current Liabilities	$393.10M	$411.60M	$341.30M	$409.40M	$337.60M
Long-Term Debt	$1.24B	$1.16B	$1.16B	$1.08B	$1.06B
Total Debt	$1.38B	$1.29B	$1.24B	$1.24B	$1.24B
Total Liabilities	$1.76B	$1.70B	$1.62B	$1.61B	$1.49B
Retained Earnings	$446.00M	$489.50M	$404.90M	$464.70M	$500.00M
Shareholders' Equity	$120.70M	$138.10M	$29.70M	$38.90M	$46.90M
Working Capital	$142.90M	$110.60M	$112.90M	$172.40M	$206.20M
Net Debt	$1.25B	$1.18B	$1.13B	$1.11B	$1.10B

NGVT Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$79.00M	$129.70M	$97.10M	-$2.00M	-$13.80M
Capital Expenditure	-$12.20M	-$11.90M	-$23.60M	-$10.30M	-$10.30M
Free Cash Flow	$66.80M	$117.80M	$73.50M	-$12.30M	-$24.10M
Depreciation & Amortisation	$25.60M	$28.00M	$27.90M	$22.70M	$22.00M
Stock-Based Compensation	$4.40M	$5.30M	$4.50M	$4.80M	$4.20M
Investing Cash Flow	-$2.80M	-$28.10M	-$15.10M	$106.30M	$75.40M
Financing Cash Flow	-$63.00M	-$94.80M	-$83.40M	-$61.80M	-$37.60M
Share Repurchases	$0.00	-$25.20M	-$31.10M	-$52.30M	-$34.50M
Net Change in Cash	$13.20M	$6.80M	-$1.40M	$42.50M	$24.00M

Market Snapshot

About

Ingevity Corp. is a specialty chemicals and activated carbon materials company serving diverse industrial markets. The company produces pine-based chemicals for adhesives, asphalt paving, and oil exploration, as well as activated carbon products for automotive emissions control and industrial purification. Ingevity operates facilities across North America, Europe, and Asia.